tert-Butyl 3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate

Catalog No. :
ACQSYM518
CAS No. :
174180-77-9
Molecular Formula :
C12H15N3O2
Molecular Weight :
233.27

IUPAC Name:tert-butyl 3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate

tert-Butyl 3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00Login to see priceIn stockInquiry
1g95%$159.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate
IUPAC Nametert-butyl 3-methyl-1H-pyrazolo[3,4-b]pyridine-1-carboxylate
MDL No.MFCD11616024
Molecular FormulaC12H15N3O2
Molecular Weight233.27
SMILESCC1=NN(C(OC(C)(C)C)=O)C2=NC=CC=C21
InChI KeyQPVJSNUQUNRAJI-UHFFFAOYSA-N
SynonymTERT-BUTYL 3-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-1-CARBOXYLATE;1-Boc-3-Methyl-1H-pyrazolo[3,4-b]pyridine;1H-Pyrazolo[3,4-b]pyridine-1-carboxylic acid, 3-methyl-, 1,1-dimethylethyl ester
CAS No.174180-77-9
PubChem CID57370583

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQSYM518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMUCD891 route compound structure diagram
    ACMUCD891116834-96-9 In Stock
  4. Then
  5. ACQSYM518 route product structure diagram
    ACQSYM518174180-77-9 In Stock
Inquiry

2. ACQSYM518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMUCD891 route compound structure diagram
    ACMUCD891116834-96-9 In Stock
  4. Then
  5. ACQSYM518 route product structure diagram
    ACQSYM518174180-77-9 In Stock
Inquiry

Comments (0)